TY - JOUR
T1 - Classification tree analysis to enhance targeting for follow-up exam of colorectal cancer screening
AU - Ishikawa, Yoshiki
AU - Zheng, Ying Fang
AU - Nishiuchi, Hiromu
AU - Suda, Takeo
AU - Hasumi, Tadahiko
AU - Saito, Hiroshi
N1 - Funding Information:
This study was supported by a Grant for the Third-Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan (H21-006) and a Cancer Research and Development Subsidy from the National Cancer Center.
PY - 2013/10/10
Y1 - 2013/10/10
N2 - Background: Follow-up rate after a fecal occult blood test (FOBT) is low worldwide. In order to increase the follow-up rate, segmentation of the target population has been proposed as a promising strategy, because an intervention can then be tailored toward specific subgroups of the population rather than using one type of intervention for all groups. The aim of this study is to identify subgroups that share the same patterns of characteristics related to follow-up exams after FOBT. Methods: The study sample consisted of 143 patients aged 50-69 years who were requested to undergo follow-up exams after FOBT. A classification tree analysis was performed, using the follow-up rate as a dependent variable and sociodemographic variables, psychological variables, past FOBT and follow-up exam, family history of colorectal cancer (CRC), and history of bowel disease as predictive variables. Results: The follow-up rate in 143 participants was 74.1% (n = 106). A classification tree analysis identified four subgroups as follows; (1) subgroup with a high degree of fear of CRC, unemployed and with a history of bowel disease (n = 24, 100.0% follow-up rate), (2) subgroup with a high degree of fear of CRC, unemployed and with no history of bowel disease (n = 17, 82.4% follow-up rate), (3) subgroup with a high degree of fear of CRC and employed (n = 24, 66.7% follow-up rate), and (4) subgroup with a low degree of fear of CRC (n = 78, 66.7% follow-up rate). Conclusion: The identification of four subgroups with a diverse range of follow-up rates for CRC screening indicates the direction to take in future development of an effective tailored intervention strategy.
AB - Background: Follow-up rate after a fecal occult blood test (FOBT) is low worldwide. In order to increase the follow-up rate, segmentation of the target population has been proposed as a promising strategy, because an intervention can then be tailored toward specific subgroups of the population rather than using one type of intervention for all groups. The aim of this study is to identify subgroups that share the same patterns of characteristics related to follow-up exams after FOBT. Methods: The study sample consisted of 143 patients aged 50-69 years who were requested to undergo follow-up exams after FOBT. A classification tree analysis was performed, using the follow-up rate as a dependent variable and sociodemographic variables, psychological variables, past FOBT and follow-up exam, family history of colorectal cancer (CRC), and history of bowel disease as predictive variables. Results: The follow-up rate in 143 participants was 74.1% (n = 106). A classification tree analysis identified four subgroups as follows; (1) subgroup with a high degree of fear of CRC, unemployed and with a history of bowel disease (n = 24, 100.0% follow-up rate), (2) subgroup with a high degree of fear of CRC, unemployed and with no history of bowel disease (n = 17, 82.4% follow-up rate), (3) subgroup with a high degree of fear of CRC and employed (n = 24, 66.7% follow-up rate), and (4) subgroup with a low degree of fear of CRC (n = 78, 66.7% follow-up rate). Conclusion: The identification of four subgroups with a diverse range of follow-up rates for CRC screening indicates the direction to take in future development of an effective tailored intervention strategy.
KW - Classification tree analysis
KW - Colorectal neoplasms
KW - Diagnostic examination
KW - Early detection of cancer
KW - Occult blood
KW - Patient compliance
UR - http://www.scopus.com/inward/record.url?scp=84885909225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885909225&partnerID=8YFLogxK
U2 - 10.1186/1471-2407-13-470
DO - 10.1186/1471-2407-13-470
M3 - Article
C2 - 24112563
AN - SCOPUS:84885909225
SN - 1471-2407
VL - 13
JO - BMC Cancer
JF - BMC Cancer
M1 - 470
ER -